Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000488971 | SCV000577260 | uncertain significance | not provided | 2017-04-06 | criteria provided, single submitter | clinical testing | The R871H variant in the ACTN1 gene has not been reported previously as a germline pathogenic variant, nor as a benign variant, to our knowledge. The R871H variant is observed in 9/9776 (0.09%) alleles from individuals of African background in the ExAC dataset (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R871H variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret R871H as a variant of uncertain significance. |
Labcorp Genetics |
RCV000488971 | SCV003500108 | likely benign | not provided | 2022-07-23 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000488971 | SCV005191452 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003962357 | SCV004785612 | likely benign | ACTN1-related disorder | 2022-04-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |